静脉注射铁单疗对2-3级化疗诱导的贫血的潜在益处,不论转移素和水平如何
Tomoko Ueda1, Hiroshi Tsubamoto1, Haruka Honda1
1Department of Obstetrics and Gynecology, School of Medicine, Hyogo Medical University, Nishinomiya, JPN.
Cureus
|January 16, 2026
概括
高剂量静脉注射铁可能有利于一些患有重症化疗诱导性贫血 (CIA) 的患者. 转激素和 (TSAT) 不能可靠地预测反应,这表明例行测试可能不必对CIA管理.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 化疗诱导的贫血 (CIA) 是一个常见的并发症.
- 高剂量静脉注射 (IV) 铁单疗法在严重的CIA (Hb <10 g/dL) 中的有效性尚未得到充分证实.
- 转激素和 (TSAT) 对CIA中IV铁反应的预测值需要进一步调查.
研究的目的:
- 评估高剂量静脉注射铁单疗法在癌症患者的有效性,严重的CIA.
- 评估TSAT和血清费里丁对治疗反应的预测价值.
- 根据20%的TSAT截止值来确定响应率.
主要方法:
- 癌症患者接受IV铁糖糖糖盐酸或铁糖糖盐酸的回顾性审查.
- 主要终点:血红蛋白 (Hb) 在一个月内增加≥1g/dL.
- 通过TSAT水平分层对应率的分析 (<20%对≥20%).
主要成果:
- 40%的患者 (n=20) 预治疗Hb的中位数为8.5g/dL,Hb增加≥1g/dL.
- 在TSAT<20% (36%) 和TSAT≥20% (40%) 组之间,响应率相似.
- 没有发现响应与血清费里水平或铁剂量之间有显著的关联.
结论:
- 高剂量IV铁单疗对2-3级CIA患者的一个子组显示出潜在的益处.
- 常规TSAT或费里丁测量可能不必用于管理CIA,特别是对于不适合使用红色素形成刺激剂的患者.
相关概念视频
01:28The Early Endosome: Endocytosis of Transferrin
4.7K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.7K
01:22Bone Marrow Sampling and Transplants
899
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
899
01:29Venous Thrombosis III: Interprofessional Care
280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
233
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
233
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
271
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
271
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K